BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 19951209)

  • 1. Adherence to cervical cancer screening guidelines for U.S. women aged 25-64: data from the 2005 Health Information National Trends Survey (HINTS).
    Nelson W; Moser RP; Gaffey A; Waldron W
    J Womens Health (Larchmt); 2009 Nov; 18(11):1759-68. PubMed ID: 19951209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deaf Women's Health: Adherence to Breast and Cervical Cancer Screening Recommendations.
    Kushalnagar P; Engelman A; Simons AN
    Am J Prev Med; 2019 Sep; 57(3):346-354. PubMed ID: 31377087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
    Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-reported history of Pap-smear in HIV-positive women in Northern Italy: a cross-sectional study.
    Dal Maso L; Franceschi S; Lise M; De' Bianchi PS; Polesel J; Ghinelli F; Falcini F; Finarelli AC;
    BMC Cancer; 2010 Jun; 10():310. PubMed ID: 20565935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast, Cervical, and Colorectal Cancer Screening Adherence: Effect of Low Body Mass Index in Women.
    Charkhchi P; Schabath MB; Carlos RC
    J Womens Health (Larchmt); 2020 Jul; 29(7):996-1006. PubMed ID: 31928405
    [No Abstract]   [Full Text] [Related]  

  • 6. Barriers and missed opportunities in breast and cervical cancer screening among women aged 50 and over, New York City, 2002.
    Nash D; Chan C; Horowitz D; Vlahov D
    J Womens Health (Larchmt); 2007; 16(1):46-56. PubMed ID: 17324096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Lerdlukanavonge P; Koonchote S
    Int J Epidemiol; 1995 Jun; 24(3):493-8. PubMed ID: 7672887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial/Ethnic Differences Affecting Adherence to Cancer Screening Guidelines Among Women.
    Hirth JM; Laz TH; Rahman M; Berenson AB
    J Womens Health (Larchmt); 2016 Apr; 25(4):371-80. PubMed ID: 26579735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Women's knowledge about cervical cancer risk factors, screening, and reasons for non-participation in cervical cancer screening programme in Estonia.
    Kivistik A; Lang K; Baili P; Anttila A; Veerus P
    BMC Womens Health; 2011 Sep; 11():43. PubMed ID: 21951661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent Disparities in Cervical Cancer Screening Uptake: Knowledge and Sociodemographic Determinants of Papanicolaou and Human Papillomavirus Testing Among Women in the United States.
    Johnson NL; Head KJ; Scott SF; Zimet GD
    Public Health Rep; 2020; 135(4):483-491. PubMed ID: 32516053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papanicolaou test use among reproductive-age women at high risk for cervical cancer: analyses of the 1995 National Survey of Family Growth.
    Hewitt M; Devesa S; Breen N
    Am J Public Health; 2002 Apr; 92(4):666-9. PubMed ID: 11919069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding women's hesitancy to undergo less frequent cervical cancer screening.
    Gerend MA; Shepherd MA; Kaltz EA; Davis WJ; Shepherd JE
    Prev Med; 2017 Feb; 95():96-102. PubMed ID: 27932055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast and cervical cancer screening in obese minority women.
    Ferrante JM; Chen PH; Jacobs A
    J Womens Health (Larchmt); 2006 Jun; 15(5):531-41. PubMed ID: 16796480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Papillomavirus Testing by Veterans Administration Women's Health Providers: Are They Adhering to Guidelines?
    Hallett LD; Gerber MR
    J Womens Health (Larchmt); 2018 Feb; 27(2):179-182. PubMed ID: 28885082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
    Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
    J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlates of Cervical Cancer Screening Adherence Among Women in the U.S.: Findings from HINTS 2013-2014.
    Luque JS; Tarasenko YN; Chen C
    J Prim Prev; 2018 Aug; 39(4):329-344. PubMed ID: 29876723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
    Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in cervical cancer screening and follow-up for black and white women in the United States.
    Ford S; Tarraf W; Williams KP; Roman LA; Leach R
    Gynecol Oncol; 2021 Feb; 160(2):369-374. PubMed ID: 33323276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The frequency of Pap smear screening in the United States.
    Sirovich BE; Welch HG
    J Gen Intern Med; 2004 Mar; 19(3):243-50. PubMed ID: 15009779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge and intention to participate in cervical cancer screening after the human papillomavirus vaccine.
    Anhang Price R; Koshiol J; Kobrin S; Tiro JA
    Vaccine; 2011 Jun; 29(25):4238-43. PubMed ID: 21473953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.